Trending: Pfizer's 2024 Guidance Disappoints
14 December 2023 - 2:28AM
Dow Jones News
9:58 ET--Pfizer is one of the most mentioned companies in the
U.S. across all news items in the last 12 hours, according to
Factiva data. The drugmaker issued 2024 guidance that fell short of
Wall Street's expectations and warned that revenue could decline
next year amid a continued slowdown in demand for its Covid-19
vaccine and related products. Pfizer shares fall more than 9% and
hit a 52-week low. Dow Jones & Co. owns Factiva.
(colin.kellaher@wsj.com)
(END) Dow Jones Newswires
December 13, 2023 10:13 ET (15:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Oct 2024 to Nov 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Nov 2023 to Nov 2024